Results 151 to 160 of about 77,752 (295)
ABSTRACT A plethora of cellular signaling pathways are dysregulated in cancer cells, promoting carcinogenesis and migration. Cholesterol has recently been linked to cancer by several subcellular mechanisms, especially by its involvement in the formation of lipid rafts, which promote oncogenic signaling and cancer cell invasion. Squalene synthase (SQS),
Danai Mavridi +2 more
wiley +1 more source
Cd36 knockout mice are protected against lithogenic diet-induced gallstones [PDF]
Abumrad, Nada A. +9 more
core +2 more sources
Ageing acts as a double‐edged sword in cancer. In the elderly, open chromatin, immunosenescence, and chronic inflammation drive SASP (IL‐6, MMPs), MDSC accumulation and T‐cell suppression, fostering tumor‐promoting microenvironments and limited therapeutic benefit.
Qi Wang +7 more
wiley +1 more source
Krüppel-like factor 2 promotes liver steatosis through upregulation of CD36
Jinlian Chen +3 more
openalex +1 more source
CD36 and CD14 immunoreactivity of Reiter cells in inflammatory synovial fluids [PDF]
Enrico Selvi +4 more
openalex +1 more source
Utilizing a clinically relevant course of treatment, our study reveals that glucocorticoids protect against the late NLRP3 inflammasome activation regulating the IL‐1β secretion, the processing of GSDM‐D and pyroptosis following signal 2 stimulation. These potent anti‐inflammatory effects are mediated by the activation of GR signaling and the expansion
David Diaz‐Jimenez +11 more
wiley +1 more source
Discovery and in vitro characterization of a human anti-CD36 scFv
IntroductionCD36 is a membrane receptor that participates in the cellular uptake of fatty acids and lipid metabolism. CD36 overexpression favors progression of different pathologies, such as atherosclerosis and cancer.
Cecilia Mata-Cruz +10 more
doaj +1 more source
The immune cell landscape in kidneys of patients with lupus nephritis. [PDF]
Lupus nephritis is a potentially fatal autoimmune disease for which the current treatment is ineffective and often toxic. To develop mechanistic hypotheses of disease, we analyzed kidney samples from patients with lupus nephritis and from healthy control
Accelerating Medicines Partnership in SLE network +43 more
core

